Hudson River Biotechnology
Series AWageningen, NetherlandsAug 2021
Hudson River Biotechnology raised €5.0M in a Series A round in Aug 2021. The company is based in Wageningen, Netherlands. Investors in the round: Bridford Group. Data as of Nov 2026.
Amount raised
€5.0M
€5,000,000
Native amount
5,000,000 EUR
Stage
Series A
series a
Investors
1
Provenance & confidence
Low confidenceAmount
Reported in EUR — no conversion. €5.0M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.